In AD, the accumulation of amyloid-β and tau protein, key hallmarks of neurodegeneration, has been implicated in osteoporosis development by modulating neuropeptide Y (NPY) expression, which impacts bone density and the trabecular architecture [222]. This evidence concerns the gene NPY and Alzheimer disease.